中东和非洲皮肤癌诊断市场预测至 2028 年 - COVID-19 影响和按类型（黑色素瘤和非黑色素瘤）和筛查类型（血液测试、皮肤镜检查、影像测试、淋巴结活检和皮肤活检）进行的区域分析
No. of Pages: 88 | Report Code: TIPRE00029076 | Category: Life Sciences
No. of Pages: 88 | Report Code: TIPRE00029076 | Category: Life Sciences
技术先进的皮肤镜有助于更好地可视化皮肤癌，并将诊断灵敏度提高了 10-30%。同样，人工智能技术的发展使其能够应用于皮肤癌的早期检测。 2022 年 2 月，位于波尔图和里斯本的弗劳恩霍夫辅助信息和通信解决方案中心 (AICOS) 的研究人员发布了他们的 Derm.AI 软件，该软件可以对皮肤表面看起来有潜在危险的皮肤病变进行顺利的初步评估。它将智能手机拍摄的皮肤病变照片与图像分析软件和人工智能相结合。该软件可能会帮助皮肤科医生访问和分析皮肤癌的病例和风险。目前，Derm.AI 解决方案的研究人员旨在改进葡萄牙国家卫生系统现有的远程皮肤病治疗流程。他们还致力于开发用于分析移动应用程序结果的解决方案，进一步增强 Derm.AI 的深度学习模型。该软件是与卫生部和临床合作伙伴（即 IPO Coimbra、CHUP 和 ULS Guarda）的共享服务合作开发的。
凭借新功能和技术，供应商吸引新客户并扩大其在新兴市场的足迹。这一因素正在推动中东和非洲地区的增长。非洲皮肤癌诊断市场复合年增长率前景广阔。
皮肤癌诊断市场分为以下类型和筛选类型。根据类型，市场分为黑色素瘤和非黑色素瘤。根据筛查类型，市场分为皮肤活检、皮肤镜检查、淋巴结活检、影像学检查和血液检查。根据国家/地区，市场分为阿联酋、沙特阿拉伯、南非以及中东其他地区和地区。非洲。
AMLo Biosciences Limited； DermLite 有限责任公司；生物梅里埃公司；霍夫曼-拉罗氏有限公司；和 Michelson Diagnostics Ltd. 是中东和非洲地区的领先公司之一。非洲皮肤癌诊断市场。
Strategic insights for Middle East and Africa Skin Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 160.5 Million |
| Market Size by 2028 | US$ 214.3 Million |
| Global CAGR (2021 - 2028) | 4.2% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East and Africa Skin Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Skin Cancer Diagnostics Market is valued at US$ 160.5 Million in 2021, it is projected to reach US$ 214.3 Million by 2028.
As per our report Middle East and Africa Skin Cancer Diagnostics Market, the market size is valued at US$ 160.5 Million in 2021, projecting it to reach US$ 214.3 Million by 2028. This translates to a CAGR of approximately 4.2% during the forecast period.
The Middle East and Africa Skin Cancer Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Skin Cancer Diagnostics Market report:
The Middle East and Africa Skin Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Skin Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Skin Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Skin Cancer Diagnostics Market
